文献速递神经康复

经颅直流电刺激调节炎症标志物改善卒中后认知障碍与抑郁:一项探索性随机试验

TDCS Modulates Inflammatory Markers to Improve Post-Stroke Cognitive Impairment and Depression: An Exploratory Randomized Trial.
PubMed 文献 · Neurorehabil Neural Repair · 2026-05-14

该探索性随机试验将60例缺血性卒中患者分为活性tDCS组(2 mA,每天20分钟,刺激患侧背外侧前额叶皮层)与假刺激组,均联合常规康复4周。结果显示活性tDCS组IL-6和TNF-α显著下降,MoCA和HAMD评分改善优于对照组,且IL-6与TNF-α变化可预测认知改善。

要点

  • 活性tDCS联合常规康复4周可降低卒中患者IL-6和TNF-α水平
  • 活性tDCS组MoCA和HAMD评分改善显著优于假刺激组
  • ΔIL-6和ΔTNF-α可预测MoCA评分改善,ΔIL-6和病程可预测HAMD改善

核心结论

  • tDCS联合常规康复治疗可能降低促炎细胞因子水平并改善认知与抑郁症状,支持其作为抗炎神经康复疗法的潜在应用。

研究设计与样本

  • 探索性随机对照试验,60例患者随机分为实验组(n=30,活性tDCS 2 mA,每天20分钟,刺激患侧背外侧前额叶皮层)和对照组(n=30,假刺激),均联合标准康复4周。

主要发现

  • 干预后仅实验组IL-6和TNF-α显著下降(均P < .01),IL-1β和IL-10无变化(P > .05)。
  • 实验组MoCA和HAMD评分改善大于对照组(P = .01和.04)。
  • ΔIL-6和ΔTNF-α预测MoCA评分改善(R2 = .607,P < .01)。
  • ΔIL-6和病程预测HAMD评分改善(R2 = .501,P < .01)。

关键数值与推荐

  • 活性tDCS参数:2 mA,每天20分钟,刺激患侧背外侧前额叶皮层,持续4周。
  • 炎症标志物采用ELISA法测定血清IL-1β、IL-6、IL-10和TNF-α。
  • 认知和抑郁分别采用MoCA和HAMD评估。

临床怎么用

  • 对缺血性卒中后认知障碍和抑郁患者,可考虑在常规康复基础上联合活性tDCS(2 mA,每天20分钟,患侧DLPFC,4周)。
  • 治疗前后可监测血清IL-6和TNF-α水平,作为炎症相关改善的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundPeripheral inflammatory markers may serve as indicators of cognitive impairment and depression after ischemic stroke. Post-stroke cognitive impairment hinders rehabilitation and quality of life. Transcranial direct current stimulation (tDCS) is a promising non-invasive intervention, but its link to inflammatory changes and clinical improvement remains unclear.ObjectiveTo evaluate tDCS effects on cognition and depression in stroke patients, and to examine if inflammatory marker changes underlie these effects.MethodsSixty patients were randomized to an experimental group (EG, n = 30) receiving active tDCS (2 mA, 20 minutes/day over affected dorsolateral prefrontal cortex) or a control group (CG, n = 30) receiving sham stimulation, alongside standard rehabilitation for 4 weeks. Serum interleukin-1β ( IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α) levels were measured by enzyme-linked immunosorbent assay (ELISA) pre- and post-intervention. Cognition and depression were assessed using Montreal Cognitive Assessment (MoCA) and Hamilton Depression Scale (HAMD).ResultsPost-intervention, only the EG showed significant reductions in IL-6 and TNF-α (both P < .01), with no change in IL-1β or IL-10 (P > .05). The EG demonstrated greater improvement in MoCA and HAMD scores than the CG (P = .01 and .04). Changes in IL-6 (ΔIL-6) and TNF-α (ΔTNF-α) predicted improvements in MoCA scores (ΔMoCA, R2 = .607, P < .01). ΔIL-6 and disease duration predicted improvements in HAMD scores (ΔHAMD, R2 = .501, P < .01).ConclusiontDCS combined with conventional rehabilitation therapies may reduce pro-inflammatory cytokine levels and improve cognitive and depressive symptoms, supporting its potential application as an anti-inflammatory neurorehabilitation therapy.Clinical Trial registrationStudy on the mechanism of transcranial direct current stimulation in the intervention of working memory decline after stroke, https://www.chictr.org.cn/showproj.html?proj=208836, ChiCTR2300077242.

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Liu J, Li W, Li W, et al. TDCS Modulates Inflammatory Markers to Improve Post-Stroke Cognitive Impairment and Depression: An Exploratory Randomized Trial. Neurorehabil Neural Repair. 2026. PMID: 42132480. doi:10.1177/15459683261442186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。